Current clinical practice of cardiac resynchronization therapy in Turkey: Reflections from Cardiac Resynchronization Therapy Survey-II
暂无分享,去创建一个
K. Dickstein | S. Saygi | C. Linde | T. Altin | A. Bilge | H. Kabul | A. Akyol | S. Cay | D. Kocyigit | M. Demir | C. Normand | E. E. Özcan | I. Başarıcı | E. Örnek | B. Ikitimur | V. Polat | N. U. Sarıgül | H. A. Gümrükçüoğlu | K. Gemici | S. Çay
[1] M. Eren,et al. [Snapshot evaluation of heart failure in Turkey: Baseline characteristics of SELFIE-TR]. , 2019, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.
[2] J. Pogue,et al. Defibrillation testing and clinical outcomes after implantable cardioverter-defibrillator implantation in patients in atrial fibrillation at the time of implant: An analysis from the SIMPLE trial. , 2019, Heart rhythm.
[3] Jagmeet P. Singh,et al. Indications for Cardiac Resynchronization Therapy: A Comparison of the Major International Guidelines. , 2018, JACC. Heart failure.
[4] G. Hindricks,et al. CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients—who is doing what to whom and how? , 2018, European journal of heart failure.
[5] A. Auricchio,et al. Defibrillator shocks and their effect on objective and subjective patient outcomes: Results of the PainFree SST clinical trial. , 2017, Heart rhythm.
[6] J. Healey,et al. Wilkoff BL, et al. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[7] G. Hindricks,et al. European cardiac resynchronization therapy survey II: rationale and design. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[8] J. Nielsen,et al. ESC Guidelines on cardiac pacing and cardiac resynchronization therapy , 2014 .
[9] Lluís Mont,et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, European heart journal.
[10] Biykem Bozkurt,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.
[11] O. Ergene,et al. [Heart failure prevalence and predictors in Turkey: HAPPY study]. , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.
[12] Leslie Saxon,et al. Effects of Cardiac Resynchronization Therapy With or Without a Defibrillator on Survival and Hospitalizations in Patients With New York Heart Association Class IV Heart Failure , 2006, Circulation.
[13] J. Daubert,et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.
[14] C. O'connor,et al. A standardized definition of ischemic cardiomyopathy for use in clinical research. , 2002, Journal of the American College of Cardiology.
[15] J. Daubert,et al. Four Chamber Pacing in Dilated Cardiomyopathy , 1994, Pacing and clinical electrophysiology : PACE.
[16] F W Prinzen,et al. Redistribution of myocardial fiber strain and blood flow by asynchronous activation. , 1990, The American journal of physiology.